 NEW YORK and RESEARCH TRIANGLE PARK, N.C., March 29, 2021 GLOBE NEWSWIRE -- Sio Gene Therapies Inc. NASDAQ: SIOX, a clinical-stage company focused on developing gene therapies to radically improve the lives of patients with neurodegenerative diseases, announced today that the company will participate in select upcoming investor and scientific conferences in April. Details can be found below. 